Pangaea Biotech SL:企業の製品パイプライン分析2018

GlobalDataが発行した調査報告書(DATA904C2784)
◆英語タイトル:Pangaea Biotech SL - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C2784
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:スペイン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Pangaea Biotech SL (Pangaea) is a provider of molecular diagnostics and research and development services for cancer treatment. The company discovers and develops gene signatures and prognostic markers. Its services include molecular diagnosis, in vitro drug testing, clinical trials, biomarker discovery, drug development, dx platform validation, in licensing and out licensing services. Pangaea’s molecular diagnosis services comprise gene amplification and translocation testing; mutation analysis in tumor tissue and blood, immuno-histochemistry and gene expression programs. The company improves clinical development process through discovery of novel markers and validation in tumor samples and cell lines. It operates through pharmaceutical, diagnostics and biotech companies for anti-cancer drug development. Pangaea is headquartered in Barcelona, Spain.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Pangaea Biotech SL
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Pangaea Biotech SL Company Overview 4
Pangaea Biotech SL Company Snapshot 4
Pangaea Biotech SL Pipeline Products and Ongoing Clinical Trials Overview 4
Pangaea Biotech SL – Pipeline Analysis Overview 6
Pangaea Biotech SL – Key Facts 6
Pangaea Biotech SL – Major Products and Services 7
Pangaea Biotech SL Pipeline Products by Development Stage 8
Pangaea Biotech SL Pipeline Products Overview 10
BRCA1 RNA Test 10
BRCA1 RNA Test Product Overview 10
EGFR Enrichment Test 11
EGFR Enrichment Test Product Overview 11
EGFR Serum Mutation Test 12
EGFR Serum Mutation Test Product Overview 12
Genetic Mutation Test – Breast Cancer 13
Genetic Mutation Test – Breast Cancer Product Overview 13
Genetic Mutation Test – Colon Cancer 14
Genetic Mutation Test – Colon Cancer Product Overview 14
Genetic Mutation Test – Melanoma 15
Genetic Mutation Test – Melanoma Product Overview 15
Genetic Mutation Test – Pancreatic Cancer 16
Genetic Mutation Test – Pancreatic Cancer Product Overview 16
Pangaea Biotech SL – Key Competitors 17
Pangaea Biotech SL – Key Employees 18
Pangaea Biotech SL – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Pangaea Biotech SL, Recent Developments 20
Feb 02, 2015: LABCO and PANGAEA, led by Dr Rafael Rosell, join forces to launch a non-invasive test for monitoring cancer treatment 20
Appendix 21
Methodology 21
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Pangaea Biotech SL Pipeline Products and Ongoing Clinical Trials Overview 4
Pangaea Biotech SL Pipeline Products by Equipment Type 5
Pangaea Biotech SL Pipeline Products by Indication 5
Pangaea Biotech SL, Key Facts 6
Pangaea Biotech SL, Major Products and Services 7
Pangaea Biotech SL Number of Pipeline Products by Development Stage 8
Pangaea Biotech SL Pipeline Products Summary by Development Stage 9
BRCA1 RNA Test - Product Status 10
BRCA1 RNA Test - Product Description 10
EGFR Enrichment Test - Product Status 11
EGFR Enrichment Test - Product Description 11
EGFR Serum Mutation Test - Product Status 12
EGFR Serum Mutation Test - Product Description 12
Genetic Mutation Test - Breast Cancer - Product Status 13
Genetic Mutation Test - Breast Cancer - Product Description 13
Genetic Mutation Test - Colon Cancer - Product Status 14
Genetic Mutation Test - Colon Cancer - Product Description 14
Genetic Mutation Test - Melanoma - Product Status 15
Genetic Mutation Test - Melanoma - Product Description 15
Genetic Mutation Test - Pancreatic Cancer - Product Status 16
Genetic Mutation Test - Pancreatic Cancer - Product Description 16
Pangaea Biotech SL, Key Employees 18
Glossary 23

List of Figures
Pangaea Biotech SL Pipeline Products by Equipment Type 5
Pangaea Biotech SL Pipeline Products by Development Stage 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Pangaea Biotech SL:企業の製品パイプライン分析2018(Pangaea Biotech SL - Product Pipeline Analysis, 2018 Update)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆